Brief: Sedana Medical Q4 EBIT Loss Widens To SEK 7 Mln
Feb 25 (Reuters) - Sedana Medical AB (publ) SEDANA.ST :
* FOURTH QUARTER AND YEAR-END REPORT
* Q4 NET SALES AMOUNTED TO MSE 46 (20), EQUIVALENT TO AN
INCREASE
OF 129% ON SAME PERIOD OF 2019
* Q4 EARNINGS BEFORE INTEREST AND TAXES (EBIT) AMOUNTED TO
MSEK -7
(-5), EQUIVALENT TO AN EBIT MARGIN OF -15% (-25%)
Source text for Eikon: ID:nWkr5k1s5y
Further company coverage: SEDANA.ST
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))